Doctors rarely discuss end-of-life care for chronic lung conditions

(Reuters Health) - Though most people suffering from chronic respiratory diseases want to discuss their preferences for end-of-life care with medical providers, they seldom do, a new review of past research suggests.

FDA approves Mylan's biosimilar of Roche's cancer drug Herceptin

(Reuters) - The U.S. Food and Drug Administration on Friday approved Mylan NV's biosimilar version of Roche's blockbuster breast cancer treatment Herceptin.

FDA approves Mylan's biosimilar of Roche's breast cancer treatment

(Reuters) - The U.S. Food and Drug Administration on Friday approved Mylan NV's biosimilar of Roche's blockbuster breast cancer treatment Herceptin.